Maryland PDAB Dossiers For Farxiga, Jardiance Ready For Comments

By Luke Zarzecki / June 25, 2025 at 1:58 PM

The Maryland Prescription Drug Affordability Board (PDAB) is requesting comments on whether two popular diabetes drugs have created affordability challenges in the state’s health care system or high out-of-pocket costs for patients -- a move that could set the stage for first-ever upper price limits by a state drug affordability board.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.